Lupin Limited has informed the Exchange regarding a press release dated January 21, 2026, titled Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries.
Lupin Limited has informed the Exchange regarding a press release dated January 21, 2026, titled Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries.